[HTML][HTML] Therapy in the course of kidney graft rejection—Implications for the cardiovascular system—A systematic review

J Mizera, J Pilch, U Giordano, M Krajewska, M Banasik - Life, 2023 - mdpi.com
Kidney graft failure is not a homogenous disease and the Banff classification distinguishes
several types of graft rejection. The maintenance of a transplant and the treatment of its …

Advancing kidney transplant outcomes: the role of urinary proteomics in graft function monitoring and rejection detection

M Rroji, A Figurek, G Spasovski - Expert Review of Proteomics, 2024 - Taylor & Francis
Introduction Kidney transplantation significantly improves the lives of those with end-stage
kidney disease, offering best alternative to dialysis. However, transplant success is …

[HTML][HTML] Interstitial Foci Expression of Indoleamine 2, 3-Dioxygenase 1: A Potential Biomarker for Kidney Transplant Rejection

K Wiśnicki, P Donizy, M Kuriata-Kordek… - Journal of Clinical …, 2024 - mdpi.com
(1) Background: Kidney transplantation is the best therapy for patients with end-stage renal
disease, but the risk of rejection complicates it. Indoleamine 2, 3-dioxygenase 1 (IDO1), an …

[HTML][HTML] Indoleamine 2, 3-dioxygenase 1 (IDO1) in kidney transplantation: a Guardian against rejection

K Wiśnicki, P Donizy, A Hałoń… - Journal of Clinical …, 2023 - mdpi.com
Kidney transplantation is a crucial treatment for end-stage kidney disease, with
immunosuppressive drugs helping to reduce acute rejection rates. However, kidney graft …

[PDF][PDF] Hało n

K Wisnicki, P Donizy - J. Clin. Med, 2023 - pdfs.semanticscholar.org
Kidney transplantation is a crucial treatment for end-stage kidney disease, with
immunosuppressive drugs helping to reduce acute rejection rates. However, kidney graft …